Presynaptic dopamine receptors involved in the inhibition of noradrenaline and dopamine release in the human gastric and uterine arteries

被引:13
作者
Morgadinho, MT [1 ]
Ribeiro, CAF [1 ]
Macedo, TRA [1 ]
机构
[1] Univ Coimbra, Fac Med, Inst Pharmacol & Expt Therapeut, P-3004054 Coimbra, Portugal
关键词
catecholamine release; presynaptic dopamine receptors; human gastric artery; human uterine artery; D2 dopamine receptors;
D O I
10.1111/j.1472-8206.1999.tb00378.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Electrical stimulation-induced depolarization releases both dopamine (DA) and noradrenaline (NA) from sympathetic neurones of the human gastric and uterine arteries. The overflow of catecholamines elicited by electrical stimulation was measured by using high performance liquid chromatography with electrochemical detection. The addition of yohimbine (0.01-10 mu M), an alpha(2)-adrenoceptor antagonist, to the perfusion fluid increased, in a concentration-dependent manner; the electrically-evoked DA and NA overflow from gastric and uterine arteries. In the presence of sulpiride (0.1-10 mu M), a dopamine D2-type receptor antagonist, the overflow of both amines was found to be increased in the uterine artery, but not in the gastric artery. Apomorphine (0.1-10 mu M), a dopamine receptor agonist, produced a dose-dependent inhibition in the amount of DA and NA released from gastric and uterine arteries. SCH 23390 (0.1-10 mu M), a dopamine D1 receptor antagonist, had no effect on the release of both amines in both preparations. The inhibitory effect of apomorphine was blocked by sulpiride in the gastric and uterine arteries but not bl, SCH 23390. The results presented suggest the existence of dopamine D2-type receptors in the human gastric and uterine arteries. They seem to have, in each artery, a different physiological importance. (C) 1999 Editions scientifiques el medicales Elsevier SAS.
引用
收藏
页码:662 / 670
页数:9
相关论文
共 21 条
[1]   AUTORADIOGRAPHIC LOCALIZATION OF DOPAMINE DA-1 RECEPTORS IN THE RAT RENAL VASCULATURE USING [H-3] SCH 23390 AS A LIGAND [J].
AMENTA, F ;
RICCI, A .
JOURNAL OF AUTONOMIC PHARMACOLOGY, 1990, 10 (06) :373-383
[2]   RELEASE OF NORADRENALINE AND DOPAMINE BY NERVE-STIMULATION IN THE GUINEA-PIG AND RAT VAS-DEFERENS [J].
BELL, C ;
GILLESPIE, JS ;
MACRAE, IM .
BRITISH JOURNAL OF PHARMACOLOGY, 1984, 81 (03) :563-569
[3]   FURTHER-STUDIES ON RENAL NERVE-STIMULATION INDUCED RELEASE OF NORADRENALINE AND DOPAMINE FROM THE CANINE KIDNEY INSITU [J].
BRADLEY, T ;
HJEMDAHL, P .
ACTA PHYSIOLOGICA SCANDINAVICA, 1984, 122 (03) :369-379
[4]   SUBCLASSIFICATION OF PERIPHERAL DOPAMINE-RECEPTORS [J].
BRODDE, OE .
JOURNAL OF AUTONOMIC PHARMACOLOGY, 1990, 10 :S5-S10
[5]   EVIDENCE FOR THE EXISTENCE OF PREJUNCTIONAL RECEPTOR-SITES FOR DOPAMINE IN THE MOUSE VAS-DEFERENS [J].
CARRATU, MR ;
CONTECAMERINO, D ;
DESERIO, A ;
FERRARI, E ;
MITOLOCHIEPPA, D .
JOURNAL OF THE AUTONOMIC NERVOUS SYSTEM, 1989, 27 (03) :221-228
[6]  
DUBOCOVICH ML, 1980, J PHARMACOL EXP THER, V212, P144
[7]  
FRIEDMAN DJ, 1989, J PHARMACOL EXP THER, V250, P853
[8]  
IORIO LC, 1983, J PHARMACOL EXP THER, V226, P462
[9]  
LANGER SZ, 1980, PHARMACOL REV, V32, P337
[10]  
LOKHANDWALA MF, 1984, J PHARMACOL EXP THER, V228, P161